Saved Google Search 01/12/2003 . . . courtesy of 
[Note that many of these links expire after a few weeks]
|
Preferences Search Tips | ||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
| Sort by relevance Sorted by date |
Happy
Hour
Atlantic
Online - 11 hours ago
... close
to Dad. She says, "Here's your Sinemet and your Requip and your
potassium
supplement and your Paxil, Mr. Williams.". Dad opens ...
Federal
judge rules in favor of GlaxoSmithKline in Paxil ad ...
Lakeland
Ledger, FL - 15 hours ago
A
federal judge on Monday refused to grant class action status to a lawsuit
filed
against GlaxoSmithKline over the marketing of its anti-depressant
Paxil. ...
Federal
judge rules in favor of GlaxoSmithKline in Paxil ad ...
Charlotte
Observer, NC - 15 hours ago
... YORK - A federal judge on Monday refused to grant class
action status to a lawsuit
filed against GlaxoSmithKline over the marketing
of its anti-depressant Paxil ...
Federal
judge rules in favor of GlaxoSmithKline in Paxil ad ...
Raleigh
News, NC - 15 hours ago
...
AP) - A federal judge on Monday refused to grant class action status to a
lawsuit
filed against GlaxoSmithKline over the marketing of its
anti-depressant Paxil ...
Federal
judge rules in favor of GlaxoSmithKline in Paxil ad ...
Times
Daily, AL - 16 hours ago
A federal
judge on Monday refused to grant class action status to a lawsuit
filed
against GlaxoSmithKline over the marketing of its anti-depressant
Paxil. ...
Federal
judge rules in favor of GlaxoSmithKline in Paxil ad ...
Miami
Herald, FL - 16 hours ago
... YORK - A federal judge on Monday refused to grant class
action status to a lawsuit
filed against GlaxoSmithKline over the marketing
of its anti-depressant Paxil ...
Federal
judge rules in favor of GlaxoSmithKline in Paxil ad ...
Sarasota
Herald-Tribune, FL - 16 hours ago
A federal judge on Monday refused to grant class action status to a
lawsuit filed
against GlaxoSmithKline over the marketing of its
anti-depressant Paxil. ...
In
brief:
Contra Costa
Times, CA - 17 hours ago
... A federal judge on Monday refused to grant class-action
status to a lawsuit filed
against GlaxoSmithKline over the marketing of its
anti-depressant Paxil. ...
Prognosis
'03: Many More FDA Approvals
Newsday - 19 hours ago
... serotonin. In contrast, popular antidepressants, like Prozac
and Paxil,
boost levels of serotonin only. Cymbalta also works faster.
ADHD. ...
Drugmaker
nixes border sales
Detroit Free
Press, MI - 22 hours ago
... chain," he said. "Glaxo produces all their Paxil for
the whole world
in Puerto Rico and ships it all over the world. To suggest
...
Optimism
Among CEOs
Washington
Post, DC - 13 Jan 2003
...
GlaxoSmithKline, the world's second-largest drugmaker, won't face a
class-action
trial over claims it misled consumers by calling the
antidepressant Paxil "non ...
Paxil
ad suit denied class action status
Nando
Times (subscription) - 13 Jan 2003
... EST) - A federal judge on Monday refused to grant class
action status to a lawsuit
filed against GlaxoSmithKline over the marketing
of its anti-depressant Paxil ...
Federal
judge rules in favor of GlaxoSmithKline in Paxil ad ...
NEPA News, PA - 13
Jan 2003
A federal judge on Monday refused to grant
class action status to a lawsuit filed
against GlaxoSmithKline over the
marketing of its anti-depressant Paxil. ...
Federal
judge rules in favor of GlaxoSmithKline in Paxil ad ...
Boston.com, MA - 13 Jan 2003
... AP) A federal judge on Monday refused to grant class action
status to a lawsuit filed
against GlaxoSmithKline over the marketing of its
anti-depressant Paxil. ...
Paxil
Ad Suit Fails to Get Class Status
Lakeland Ledger, FL - 13 Jan
2003
A federal judge on Monday refused to grant class
action status to a lawsuit filed
against GlaxoSmithKline over the marketing
of its anti-depressant Paxil. ...
Federal
judge rules in favor of GlaxoSmithKline in Paxil ad ...
Miami
Herald, FL - 13 Jan 2003
... YORK - A federal judge on Monday refused to grant class
action status to a lawsuit
filed against GlaxoSmithKline over the marketing
of its anti-depressant Paxil ...
Paxil Ad
Suit Fails to Get Class Status
ABC
News - 13 Jan 2003
A federal judge on
Monday refused to grant class action status to a lawsuit filed
against
GlaxoSmithKline over the marketing of its anti-depressant Paxil.
...
Paxil Ad
Suit Fails to Get Class Status
Miami
Herald, FL - 13 Jan 2003
... YORK - A federal judge on Monday refused to grant class
action status to a lawsuit
filed against GlaxoSmithKline over the marketing
of its anti-depressant Paxil ...
Paxil
Ad Suit Fails to Get Class Status
Newsday - 13 Jan 2003
... A federal judge on Monday refused to grant class action
status to a lawsuit filed
against GlaxoSmithKline over the marketing of its
anti-depressant Paxil. ...
Paxil
Ad Suit Fails to Get Class Status
Sarasota Herald-Tribune, FL - 13 Jan
2003
A federal judge on Monday refused to grant class
action status to a lawsuit filed
against GlaxoSmithKline over the marketing
of its anti-depressant Paxil. ...
Glaxo
warns Canadian drug sellers
CNN - 13 Jan 2003
... Canadian Web site CrossBorderPharmacy.com, for example,
offers Glaxo's best-selling
antidepressant, Paxil, at $127.04 for a
three-month supply of 90 tablets ...
Paxil
Ad Suit Fails to Get Class Status
Times
Daily, AL - 13 Jan 2003
A federal
judge on Monday refused to grant class action status to a lawsuit
filed
against GlaxoSmithKline over the marketing of its anti-depressant
Paxil. ...
LA
judge denies class action for Glaxo Paxil suit
Forbes - 13 Jan 2003
... A US judge in Los Angeles on Monday denied a request to
certify as a class action
a lawsuit claiming that GlaxoSmithKline Plc's
anti-depressant Paxil is habit ...
Newer
Antidepressants May Increase Bleeding Risk
Reuters, UK - 13 Jan 2003
... serotonin reuptake inhibitors. SSRIs include Paxil
(paroxetine),
Prozac (fluoxetine) and Zoloft (sertraline). "Our study showed
...
Glaxo Warns Canadian
Cos That Thrive On US Sales
Yahoo
News - 12 Jan 2003
... owner of
Aptecha.com, based in Stonewall, Manitoba, said Glaxo's action "is of
concern"
because the company's line includes several popular drugs, such as
Paxil ...
If
Everyone Were on Prozac . . .
TIME - 12 Jan 2003
Although
originally approved only for adults with "symptoms of depressive
illness,"
Prozac and its imitators (Zoloft, Paxil, Celexa, Luvox) are
taken today by ...
TIME
announces its picks for 2002
TIME - 12 Jan 2003
To be
conscious in these days of Paxil, Prozac and Dr. Phil is to
question
one's own sanity on an almost weekly basis. Self-diagnosis
...
The
Power of Mood
TIME - 12
Jan 2003
... Antidepressant drugs like Prozac,
Paxil and Zoloft, known as selective serotonin
reuptake inhibitors, or
ssris, were developed to keep serotonin from being ...
'.Net'
No More at Microsoft
Washington
Post, DC - 10 Jan 2003
...
A three-month supply of Glaxo's Paxil antidepressant sells for $127.04 on
CrossBorderPharmacy.com,
an online drugstore run by Calgary-based Total Care
Pharmacy ...
Antidepressants:
UK panel to review suicide link
UK
Comment Wire, UK - 10 Jan 2003
... In recent times, GlaxoSmithKline's top-selling product,
Seroxat (Paxil in US) has
been at the center of this attention and
faces several lawsuits alleging it ...
US
approves Prozac for children
CBC
News, Canada - 09 Jan 2003
... Prozac is part of a new class of anti-depressants called
Selective Serotonin
Reuptake Inhibitors (SSRIs). Paxil and Zoloft are
other SSRIs. ...
UK
Probes SSRI Antidepressants
Yahoo
News - 08 Jan 2003
... the
safety of the selective serotonin reuptake inhibitor (SSRI) class of
antidepressants
following claims that drugs such as GlaxoSmithKline's
Seroxat/Paxil ...
UK
Probes SSRI Antidepressants
Reuters, UK - 08 Jan 2003
... the safety of the selective serotonin reuptake inhibitor
(SSRI) class of antidepressants
following claims that drugs such as
GlaxoSmithKline's Seroxat/Paxil ...
Britain
probes safety of antidepressant drugs
Forbes - 08 Jan 2003
... The serotonin drug class includes GlaxoSmithKline Plc's
top-selling product,
Seroxat, known as Paxil in the United States,
which already faces lawsuits ...
Pick
up sticks: How to eat Chinese food
Providence Journal Bulletin, RI - 07 Jan
2003
... Can you help? To take the football
analogy further, there's a product
that can do as much for you as
Paxil did for Ricky Williams. ...
Deal
gives Glaxo breathing space
Guardian, UK - 06 Jan 2003
... Glaxo scored an initial victory at the end of last year in
its battle to defend
its top-selling drug, the anti-depressant Paxil,
from cheaper copies. ...
Some
more green stuff
Philadelphia Daily
News, PA - 06 Jan 2003
...
S. Broad Street. (Anxious? Stoke up on Paxil.). • Valley Green
Inn,
Forbidden Drive along Wissahickon Creek. (Feast on roast falcon.).
...
Action
Line
Miami
Herald, FL - 06 Jan 2003
... My mother's doctor switched the alprazolam to Paxil,
which the insurance paid
for, but I have to pay for the Exelon myself, and
it's an expensive drug. ...
The
Long Journey Back: Surviving Depression
Washington Post, DC - 05 Jan
2003
... born with. He prescribed Paxil,
trying to convince himself and me
that I was suffering from social anxiety
disorder. He assured ...
Market
Miscellany
Daily
Telegraph, UK - 04 Jan 2003
... Drugs giant GlaxoSmithKline (£12.08) reckons it can fight off
attempts by rivals
to launch copycat versions of Paxil, after a US
court upheld just one of four ...
Company
News
Creditman, UK - 04 Jan 2003
... GLAXOSMITHKLINE was cheered by a pre-trial court decision in
America that it claims
will defend Paxil, its money-spinning
antidepressant, from competition by ...
Born
to Be Happy, Through a Twist of Human Hard Wire
New York Times - 03 Jan 2003
... A study by Dr. Brian Knutson at the University of California
at San Francisco
looked at the effects of the serotonin-enhancing
antidepressant Paxil among ...
GlaxoSmithKline
buys time in Paxil court case
NEPA
News, PA - 03 Jan 2003
A federal
judge in Philadelphia gave a mixed decision in litigation over British
drug
company GlaxoSmithKline PLC's patents for anti-depressant Paxil, the
...
GlaxoSmithKline
upgraded to "accumulate"
Newratings, NY - 03 Jan 2003
... in 2002. Moreover, the company lost the Augmentin patent,
while another
drug, Paxil, has been challenged, says Jyske Bank. The
analyst ...
SkyePharma
Jumps on $120 Million Deal
ABC
News - 03 Jan 2003
... for
SkyePharma have brightened since last April following the successful
launch
of a slow-release version of GlaxoSmithKline Plc's antidepressant
Paxil CR. ...
SkyePharma
Jumps on $120 Million Deal
Reuters, UK - 03 Jan 2003
... for SkyePharma have brightened since last April following the
successful launch
of a slow-release version of GlaxoSmithKline Plc's
antidepressant Paxil CR. ...
Born
to Be Happy, Through a Twist of Human Hard Wire
New York Times - 02 Jan 2003
... A study by Dr. Brian Knutson at the University of California
at San Francisco
looked at the effects of the serotonin-enhancing
antidepressant Paxil among ...
Hard-wired
for happiness
Toronto
Star, Canada - 02 Jan 2003
... A study at the University of California looked at the effects
of the serotonin-enhancing
antidepressant Paxil among normal
volunteers, assigned at random to a ...
UK
Outlook: Threat of war makes for an uncertain year ahead
Independent, UK - 02 Jan
2003
... to be dictated in the courtrooms of the
US, particularly for GSK, which is still
fighting challenges to patents on
its biggest drug, the anti-depressant Paxil ...
CORRECTED
- Banks , oils inject life into FTSE 100 , GKN gains
Forbes - 02 Jan 2003
... a drag as it eased 1.9 percent to retrace a rise earlier this
week when investors
were encouraged by a patent ruling on its top selling
anti-depressant, Paxil. ...
CORRECTED
- Banks , oils inject life into FTSE 100 , GKN gains
Reuters, UK - 02 Jan 2003
... a drag as it eased 1.9 percent to retrace a rise earlier this
week when investors
were encouraged by a patent ruling on its top selling
anti-depressant, Paxil. ...
Banks, oils
inject life into FTSE 100, GKN gains
Forbes - 02 Jan 2003
... a drag as it eased 1.9 percent to retrace a rise earlier this
week when investors
were encouraged by a patent ruling on its top selling
anti-depressant, Paxil. ...
Banks,
oils inject life into FTSE 100, GKN gains
Reuters, UK - 02 Jan 2003
... a drag as it eased 1.9 percent to retrace a rise earlier this
week when investors
were encouraged by a patent ruling on its top selling
anti-depressant, Paxil. ...
Banks
help FTSE to edge higher, though GSK falls
Reuters, UK - 02 Jan 2003
... L fell two percent, retracing some of its gain earlier in the
week when investors
were encouraged by a patent ruling on its top selling
anti-depressant, Paxil. ...
FTSE
100 starts 2003 on weak note
Financial
Times (subscription), UK - 02 Jan 2003
... Glaxo SmithKline was also hit by profit-taking after it rose
sharply on Tuesday following
positive comments about the recent patent case
related to Paxil, its ...
British
Airways leads FTSE up but GSK slips
Reuters, UK - 02 Jan 2003
... at 1170 pence, slipping back after advances earlier in the
week, when investors were
inspired by a patent ruling on its top selling
anti-depressant drug Paxil. ...
Born
to Be Happy, Through a Twist of Human Hard Wire
New York Times - 01 Jan 2003
... A study by Dr. Brian Knutson at the University of California
at San Francisco
looked at the effects of the serotonin-enhancing
antidepressant Paxil among ...
Footsie
ends dismal year on high note
Financial
Times (subscription), UK - 01 Jan 2003
... GlaxoSmithKline headed the buoyant blue chips following
positive comment on
the recent patent case related to Paxil, its
anti-depressant drug Paxil. ...
Testosterone
tested as mood drug
Boston
Globe, MA - 01 Jan 2003
...
Psychiatrists have since abandoned such treatment for newer ideas, first
electroshock
therapy and then antidepressant drugs such as Prozac and
Paxil. ...
Eurostocks
trims gains, US consumer confidence off
The Times of Malta, Malta - 01 Jan
2003
... reaffirmed its earnings guidance and a
court ruling fuelled hopes it could head
off potential rivals to one of its
top-selling drugs, anti-depressant Paxil. ...
Viagra
may ease antidepressant side effect
Newark Star Ledger, NJ - 31 Dec
2002
... that Viagra, Pfizer's impotence
treatment, can help improve the sexual function of
men taking a class of
anti-depressants that includes Prozac, Zoloft and Paxil ...
New
Year's rant: The real trouble with liberals
WorldNetDaily - 31 Dec 2002
... Liberals take Paxil and Prozac and Wellbutrin so they
can be mellow at all
times. Liberals have come to be synonymous with wusses
and wimps. ...
Born
to Be Happy, Through a Twist of Human Hard Wire
New York Times - 31 Dec 2002
... A study by Dr. Brian Knutson at the University of California
at San Francisco
looked at the effects of the serotonin-enhancing
antidepressant Paxil among ...
Market
forces
Guardian, UK - 31 Dec 2002
... continued a recovery with a 3.9% rise as traders digested the
implications of the
substantial court victory to protect its blockbuster
anti-depressant, Paxil. ...
World
stocks: Dow snaps 4-day losing streak
New
Zealand Herald, New Zealand - 31 Dec 2002
... FTSE-100 to a positive close in thin trade and pharmaceutical
giant GlaxoSmithKline
added to the cheer after a patent ruling on its
anti-depressant drug Paxil. ...
ADR
Report-Overseas shares wrap up 2002 on flat note
Forbes - 31 Dec 2002
... The group reaffirmed its earnings guidance and a court ruling
fueled hopes it
could head off potential rivals to its antidepressant
Paxil, one of its top ...
FTSE
shrugs off 2002 woes to end session on upbeat note
Reuters, UK - 31 Dec 2002
... session, when GSK repeated its earnings guidance and a court
ruling fuelled hopes
it could head off potential rivals to one of its
top-selling drugs, Paxil. ...
Dire
year ends for eurostocks, jittery 2003 looms
Forbes - 31 Dec 2002
... reaffirmed its earnings guidance and a court ruling fuelled
hopes it could head
off potential rivals to one of its top-selling drugs,
anti-depressant Paxil. ...
UPDATE: European
Stocks Close Out 2002 In Upbeat Fashion
Yahoo Headlines - 31 Dec 2002
... chewed over the implications of GlaxoSmithKline statement
Monday that it is confident
it can prevent generic competition against its
depression drug Paxil. ...
Eurostocks
Hold Gains, US Consumer Confidence Eyed
Morningstar Canada, Canada - 31 Dec
2002
... reaffirmed its earnings guidance and a
court ruling fuelled hopes it could head
off potential rivals to one of its
top-selling drugs, anti-depressant Paxil. ...
Eurostocks
Trims Gains After US Data
ABC
News - 31 Dec 2002
... group
reaffirmed its earnings guidance and a court ruling fueled hopes it could
head
off potential rivals to one of its top-selling drugs, anti-depressant
Paxil ...
Eurostocks
trims gains, US consumer confidence off
Forbes - 31 Dec 2002
... reaffirmed its earnings guidance and a court ruling fuelled
hopes it could head
off potential rivals to one of its top-selling drugs,
anti-depressant Paxil. ...
Eurostocks
Trims Gains After US Data
Reuters, UK - 31 Dec 2002
... group reaffirmed its earnings guidance and a court ruling
fueled hopes it could head
off potential rivals to one of its top-selling
drugs, anti-depressant Paxil ...
Judge
splits decision in Glaxo case
Philadelphia Business Journal, PA - 31 Dec
2002
... District Court judge in Philadelphia
rendered a split decision Monday in a patent
dispute involving
GlaxoSmithKline's top-selling drug, the antidepressant Paxil ...
Eurostocks
hold gains, US consumer confidence eyed
Forbes - 31 Dec 2002
... reaffirmed its earnings guidance and a court ruling fuelled
hopes it could head
off potential rivals to one of its top-selling drugs,
anti-depressant Paxil. ...
European Stocks Close
Out 2002 In Upbeat Fashion
Yahoo
Headlines - 31 Dec 2002
...
chewed over the implications of GlaxoSmithKline statement Monday that it is
confident
it can prevent generic competition against its depression drug
Paxil. ...
Decision
Is Mixed in Paxil Patents Case
Newsday - 31 Dec 2002
LONDON -- A federal judge gave a mixed decision in litigation over
British drug
company GlaxoSmithKline PLC's patents for anti-depressant
Paxil, the company ...
FTSE
shrugs off 2002 woes to end session on upbeat note
Forbes - 31 Dec 2002
... session, when GSK repeated its earnings guidance and a court
ruling fuelled hopes
it could head off potential rivals to one of its
top-selling drugs, Paxil. ...
FTSE
ends higher on last day of 2002; GSK strong
Forbes - 31 Dec 2002
... giant GlaxoSmithKline closed 3.9 percent up as it continued
to benefit from hopes
that it would successfully fend off rivals to its
blockbuster drug Paxil. ...
Apotex
loses Paxil court case
National
Post, Canada - 31 Dec 2002
... criticized what it called outdated drug laws after a US judge
upheld a key patent
on anti-anxiety drug Paxil, a ruling that prevents
Apotex from launching its ...
Glaxo
wins partial victory in patent battle
icWales, UK - 31 Dec 2002
DRUGS giant GlaxoSmithKline claimed a partial victory in its battle to
prevent
the launch of generic competition to its key Paxil treatment
yesterday. ...
Dow
climbs 29, Nasdaq falls 8
Baltimore
Sun, MD - 31 Dec 2002
... A
US federal judge ruled in favor of the second-largest drugmaker, which
is
seeking to fend off cheaper competitors to its $3 billion-a-year
Paxil. ...
GSK
wins a legal round
Raleigh
News, NC - 31 Dec 2002
RESEARCH
TRIANGLE PARK -- GlaxoSmithKline has scored a tactical victory against
generic
versions of its blockbuster anti-depressant Paxil, a legal
battle that ...
Meadowbrook,
Rouge lead gains
Detroit
News, MI - 30 Dec 2002
...
won US regulatory approval for its migraine medicine and one of
GlaxoSmithKline
Plc's patents for its Paxil antidepressant received
protection from a US ...
Daily
Briefing
The News
Journal, DE - 30 Dec 2002
A
federal judge gave a mixed decision in litigation over British drug
company
GlaxoSmithKline PLC's patents for anti-depressant Paxil. ...
Gannett,
Lilly, Celadon lift state equity index
Indianapolis Star, IN - 30 Dec
2002
... Philadelphia -- A federal judge gave a
mixed decision in litigation over British
drug company GlaxoSmithKline PLC's
patents for antidepressant Paxil, the ...
Apotex
gets split decision on patent
Toronto
Star, Canada - 30 Dec 2002
has
emerged with a split decision in an American patent case
against
Glaxo-SmithKline Inc. over the anti-depression drug Paxil.
...
Apotex
wins small victory against Glaxo
The
Globe and Mail, Canada - 30 Dec 2002
... won a small victory yesterday in its legal bid to sell a
generic version of the
anti-depressant drug Paxil, after a US judge
ruled against British drug giant ...
Banks
nudge TSX back into black
The Globe and
Mail, Canada - 30 Dec 2002
... won US regulatory approval for a migraine medicine and a US
judge upheld one of GlaxoSmithKline
PLC's patents for the antidepressant
Paxil, its biggest seller. ...
Born
to Be Happy, Through a Twist of Human Hard Wire
New York Times - 30 Dec 2002
... A study by Dr. Brian Knutson at the University of California
at San Francisco
looked at the effects of the serotonin-enhancing
antidepressant Paxil among ...
Decision
Is Mixed in Paxil Patents Case
Newsday - 30 Dec 2002
LONDON -- A federal judge gave a mixed decision in litigation over
British drug
company GlaxoSmithKline PLC's patents for anti-depressant
Paxil, the company ...
Decision
Is Mixed in Paxil Patents Case
Yahoo Headlines - 30 Dec 2002
LONDON - A federal judge gave a mixed decision in litigation over
British drug
company GlaxoSmithKline PLC's patents for anti-depressant
Paxil, the company ...
Decision Is
Mixed in Paxil Patents Case
ABC
News - 30 Dec 2002
A federal judge gave
a mixed decision in litigation over British drug company
GlaxoSmithKline
PLC's patents for anti-depressant Paxil, the company
said Monday. ...
PRESS
DIGEST - Wall Street Journal - Dec 31
Forbes - 30 Dec 2002
... GlaxoSmithKline said it is confident it can prevent generic
competition to its
depression drug Paxil, despite a mixed initial
verdict in its legal case ...
Glaxo
protects Paxil patent, thwarting generic rivals
Pittsburgh Tribune
Review, PA - 30 Dec 2002
LONDON —
GlaxoSmithKline Plc said a US judge upheld one of its patents for
Paxil,
helping the world's second-biggest drugmaker fend off cheaper
competitors ...
OPEC
May Increase Supplies
Washington
Post, DC - 30 Dec 2002
Pharmacist
Donald Tierney displays Paxil in his drugstore in Wilmette,
Ill.,
yesterday. A federal judge has upheld one of GlaxoSmithKline's ...
| Google Home - Advertise with Us - Search Solutions - Services & Tools - Jobs, Press, & Help |